Hosted on MSN14h
Oppenheimer Upgrades BioMarin Pharmaceutical (BMRN)
Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...
VI Consortium1d
Oppenheimer Beach Rehabilitation Underway with $1 Million EDA Grant; Bolques Proposes Name Change
Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...
Oppenheimer upgrades BioMarin with stage set for increasing interest
Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...
BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded to Outperform at Oppenheimer
Oppenheimer upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a market perform rating to an outperform rating in a research note published on Monday morning, MarketBeat ...
Oppenheimer Reiterates Outperform Rating on NVIDIA, Citing AI Accelerator Demand
As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...
Jewish Telegraphic Agency7d
The Jewish story behind ‘Oppenheimer,’ explained
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Oppenheimer downgrades Integer on macroeconomic uncertainty
Oppenheimer downgraded Integer (ITGR) to Perform from Outperform without a price target following the Q4 report. While “fundamentally ...
Oppenheimer's Rupesh Parikh on Walmart's Q4 results: There's really no blemish in this report
Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly ...
What Analysts Think of Nvidia Stock Ahead of Earnings
Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.
MT Newswires on MSN20h
S&P 500 Companies' Earnings Growth Accelerates, Revenue Gains Slow Down, Oppenheimer Says
S&P 500 companies' latest quarterly results showed an acceleration in the pace of earnings growth and a slowdown in revenue expansion, compared with data from about a week ago, Oppenheimer Asset ...